4//SEC Filing
MCDADE MARK 4
Accession 0001209191-23-024058
CIK 0001788028other
Filed
Apr 10, 8:00 PM ET
Accepted
Apr 11, 7:55 PM ET
Size
9.8 KB
Accession
0001209191-23-024058
Insider Transaction Report
Form 4
Qiming U.S. Healthcare GP II, LLC
10% Owner
Transactions
- Purchase
Voting Common Stock
2023-01-27$1.50/sh+2,666,666$3,999,999→ 8,519,648 total
MCDADE MARK
10% Owner
Transactions
- Purchase
Voting Common Stock
2023-01-27$1.50/sh+2,666,666$3,999,999→ 8,519,648 total
Qiming U.S. Healthcare Fund II, L.P.
10% Owner
Transactions
- Purchase
Voting Common Stock
2023-01-27$1.50/sh+2,666,666$3,999,999→ 8,519,648 total
RIESCHEL GARY E
10% Owner
Transactions
- Purchase
Voting Common Stock
2023-01-27$1.50/sh+2,666,666$3,999,999→ 8,519,648 total
Footnotes (1)
- [F1]The securities are directly held by Qiming U.S. Healthcare Fund II, L.P. ("Qiming"). The general partner of Qiming is Qiming U.S. Healthcare GP II, LLC ("Qiming GP"). Gary Rieschel and Mark McDade are the managing partners of Qiming GP and may be deemed to share voting and dispositive power over the shares held by Qiming. Each of Qiming GP and Messrs. Rieschel and McDade disclaims beneficial ownership of such shares except to the extent of its or his pecuniary interest therein.
Documents
Issuer
Jasper Therapeutics, Inc.
CIK 0001788028
Entity typeother
Related Parties
1- filerCIK 0001242126
Filing Metadata
- Form type
- 4
- Filed
- Apr 10, 8:00 PM ET
- Accepted
- Apr 11, 7:55 PM ET
- Size
- 9.8 KB